Home ligand
 

Keywords :   


Tag: ligand

Ligand Pharmaceuticals Inc. (LGND) Stock Rating Reaffirmed by Roth Capital

2016-04-11 07:30:57| Biotech - Topix.net

's stock had its "buy" rating restated by equities research analysts at Roth Capital in a research report issued to clients and investors on Saturday, MarketBeat reports. Other hedge funds have made changes to their positions in the company.

Tags: rating stock capital roth

 

Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval Of EVOMELA (melphalan) For Injection

2016-03-30 07:12:27| drugdiscoveryonline Home Page

Ligand Pharmaceuticals Incorporated announces thatSpectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, received approval from the U.S. Food and Drug Administration (FDA) of EVOMELA

Tags: partner approval spectrum receives

 
 

Want To Own The Biopharma Industry? Buy Ligand Pharmaceuticals

2016-03-28 17:34:50| Chemicals - Topix.net

I am always on the lookout for companies with sound business model especially those in the healthcare sector. Recently, I wrote about Cambrex and China Biologics which you can find here and here .

Tags: buy industry pharmaceuticals ligand

 

Ligand Pharmaceuticals Inc. to Post Q1 2016 Earnings of $0.46 Per...

2016-02-16 05:34:10| Biotech - Topix.net

Ligand Pharmaceuticals Inc. - Equities research analysts at Craig Hallum upped their Q1 2016 earnings estimates for shares of Ligand Pharmaceuticals in a research report issued to clients and investors on Thursday, according to Zacks Investment Research . Craig Hallum analyst M. Tiampo now anticipates that the brokerage will post earnings of $0.46 per share for the quarter, up from their prior forecast of $0.44.

Tags: per post earnings pharmaceuticals

 

Ligand Pharmaceuticals Lowered to Hold at Zacks

2015-08-23 17:16:33| Biotech - Topix.net

According to Zacks, "Ligand delivered better-than-expected second-quarter results with the company beating both top- and bottom-line estimates. Ligand's Captisol formulation technology has resulted in partnerships with several leading health care companies like Novartis, Amgen and Pfizer among others that provide the company with funds in the form of milestone and royalty payments.

Tags: hold lowered pharmaceuticals ligand

 

Sites : [1] [2] [3] [4] next »